Relapsed Hodgkin's Lymphoma: Clinical Trials

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	1	Unknown 1
Phase 2	1	Unknown 1

Follow Relapsed Hodgkin's Lymphoma: new trials by email Literature Review of Relapsed Hodgkin's Lymphoma trials Research Report on Relapsed Hodgkin's Lymphoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion) GLIDE - Hematologic Cancer, Relapse Leukemia	Phase 1 / Phase 2	Unknown	Ciusss de L'Est de l'Île de Montréal	20	2017-02-06	2017-12-06

Narrower conditions

Hematologic Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Blood Protein Disorders (1)  ·  Bone Marrow Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Myeloid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoproliferative Disorders (1)

Sponsors

Ciusss de L'Est de l'Île de Montréal (1)

Countries

Canada (1)

Top investigators

Denis-Claude Roy, MD PhD (1)  ·  Silvy Lachance, MD (1)